Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

June 01, 1993; Volume 265,Issue 3

Article

  • You have access
    ERRATUM
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1566-1;
  • You have access
    Modification of the behavioral effects of the selective dopamine D2 agonist (+)-4-propyl-9-hydroxynaphthoxazine by dopamine antagonists in monkeys.
    S Rosenzweig-Lipson and J Bergman
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1039-1046;
  • You have access
    Adrenochrome reaction implicates oxygen radicals in metabolism of cyclosporine A and FK-506 in rat and human liver microsomes.
    S S Ahmed, H W Strobel, K L Napoli and J Grevel
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1047-1054;
  • You have access
    Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonist.
    J Willetts, D B Clissold, T L Hartman, R R Brandsgaard, G S Hamilton and J W Ferkany
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1055-1062;
  • You have access
    Modulation of the seizure threshold for excitatory amino acids in mice by antiepileptic drugs and chemoconvulsants.
    K G Steppuhn and L Turski
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1063-1070;
  • You have access
    Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone.
    D T Lysle, M E Coussons, V J Watts, E H Bennett and L A Dykstra
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1071-1078;
  • You have access
    Evidence for beta adrenergic receptor involvement in the immunomodulatory effects of morphine.
    K Fecho, L A Dykstra and D T Lysle
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1079-1087;
  • You have access
    Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonistic.
    P C Wong, P E Aldrich, A T Chiu, R A Earl, S D Hart, A L Johnson, P Ma, D E McCall, W A Price and R D Smith
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1088-1095;
  • You have access
    Endothelium- and beta-2 adrenoceptor-independent relaxation of rat aorta by tyramine and certain other phenylethylamines.
    D R Varma and S Chemtob
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1096-1104;
  • You have access
    The inotropic and beta blocking effects of a chimeric molecule that putatively inhibits both type III phosphodiesterase and beta adrenoceptors in anesthetized dogs.
    J E Shaffer, M K Grizzle, D K Anderson and T N Wheeler
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1105-1112;
  • You have access
    The oral antihypertensive activity of the methylated derivatives of phenyl-2-aminoethyl sulfide.
    S H Pollock, M I Reichbaum, J C Colbert, P A Husain, J M Holbrook, A A Ogonowski, J S Khlief and S W May
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1113-1117;
  • You have access
    Characterization of methotrexate elimination and interaction with indomethacin and flurbiprofen in the isolated perfused rat kidney.
    P Statkevich, D J Fournier and K R Sweeney
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1118-1124;
  • You have access
    Comparison of the in vitro and in vivo cardiovascular effects of two structurally distinct Ca++ channel activators, BAY K 8644 and FPL 64176.
    D Rampe, B Anderson, V Rapien-Pryor, T Li and R C Dage
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1125-1130;
  • You have access
    Losartan prevents salt-induced hypertension in reduced renal mass rats.
    N L Kanagy and G D Fink
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1131-1136;
  • You have access
    Oxidative stress and thiol modification induced by chronic administration of haloperidol.
    B R Shivakumar and V Ravindranath
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1137-1141;
  • You have access
    Characterization of indolidan- and rolipram-sensitive cyclic nucleotide phosphodiesterases in canine and human cardiac microsomal fractions.
    C Lugnier, B Muller, A Le Bec, C Beaudry and E Rousseau
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1142-1151;
  • You have access
    Effect of the chronic dose of diazepam on the intensity and characteristics of the precipitated abstinence syndrome in the dog.
    J W Sloan, W R Martin and E Wala
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1152-1162;
  • You have access
    Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal.
    R R Griffiths, S M Evans, J J Guarino, J D Roache, W R Furman, I Liebson and E M Schwam
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1163-1174;
  • You have access
    Ion channel involvement in the acute vascular effects of thiazide diuretics and related compounds.
    J A Calder, M Schachter and P S Sever
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1175-1180;
  • You have access
    Speed of action of various muscle relaxants at the neuromuscular junction binding vs. buffering hypothesis.
    M I Glavinovic, J C Law Min, L Kapural, F Donati and D R Bevan
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1181-1186;
  • You have access
    Putative, selective inhibitors of sarcoplasmic reticulum Ca+(+)-pump ATPase inhibit relaxation by nitroglycerin and atrial natriuretic factor of the rabbit aorta contracted by phenylephrine.
    D L Luo, M Nakazawa, T Ishibashi, K Kato and S Imai
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1187-1192;
  • You have access
    Acute administration of haloperidol enhances dopaminergic transmission.
    T I Lidsky and S P Banerjee
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1193-1198;
  • You have access
    Acute effects of calcitonin gene-related peptide on the mechanical and electrical responses of the rat hemidiaphragm.
    N W Fleming, B K Lewis, D A White and K L Dretchen
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1199-1204;
  • You have access
    Progesterone and mifepristone modify principally the responses of circular myometrium to oxytocin in preparturient rats: comparison with responses to acetylcholine and to calcium.
    A el Alj, N Winer, H Lallaoui, R Delansorne, F Ferre and G Germain
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1205-1212;
  • You have access
    Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle.
    T J Torphy, B J Undem, L B Cieslinski, M A Luttmann, M L Reeves and D W Hay
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1213-1223;
  • You have access
    Tachykinins and reflexly evoked atropine-resistant motility in the guinea pig colon in vivo.
    S Giuliani, A Lecci, A Giachetti and C A Maggi
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1224-1231;
  • You have access
    Dobutamine pharmacokinetics and pharmacodynamics in normal children and adolescents.
    R A Berg, J F Padbury, R L Donnerstein, S E Klewer and J J Hutter
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1232-1238;
  • You have access
    N-acetylcysteine inhibits angiotensin converting enzyme in vivo.
    S Boesgaard, J Aldershvile, H E Poulsen, S Christensen, H Dige-Petersen and J Giese
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1239-1244;
  • You have access
    Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats.
    S S Negus, S J Henriksen, A Mattox, G W Pasternak, P S Portoghese, A E Takemori, M B Weinger and G F Koob
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1245-1252;
  • You have access
    Feeding induced by opioid stimulation of the ventral striatum: role of opiate receptor subtypes.
    V P Bakshi and A E Kelley
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1253-1260;
  • You have access
    Dose- and time-dependent changes in phencyclidine metabolite covalent binding in rats and the possible role of CYP2D1.
    S M Owens, M Gunnell, E M Laurenzana and J L Valentine
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1261-1266;
  • You have access
    Indomethacin- and desamino-8-D-arginine vasopressin-induced lithium reabsorption is not amiloride sensitive in humans.
    J A Bijlsma, H A Koomans, W H Boer, E J Dorhout Mees and H J van Rijn
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1267-1271;
  • You have access
    Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines.
    D L Nelson, V L Lucaites, J E Audia, J S Nissen and D B Wainscott
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1272-1279;
  • You have access
    Modulation of cardiac performance by amiloride and several selected derivatives of amiloride.
    G N Pierce, W C Cole, K Liu, H Massaeli, T G Maddaford, Y J Chen, C D McPherson, S Jain and D Sontag
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1280-1291;
  • You have access
    On the mechanism of action of the beta-1 partial agonist denopamine in regulation of myocardial contractility: effects on myocardial alpha adrenoceptors and intracellular Ca++ transients.
    M Kohi, I Norota, M Takanashi and M Endoh
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1292-1300;
  • You have access
    Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats.
    K Sathirakul, H Suzuki, K Yasuda, M Hanano, O Tagaya, T Horie and Y Sugiyama
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1301-1312;
  • You have access
    Inhibition of gastric acid secretion in vivo and in vitro by an inhibitor of Cl(-)-HCO3- exchanger, 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid.
    S Horie, S Yano and K Watanabe
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1313-1318;
  • You have access
    Acute uptake inhibition increases extracellular serotonin in the rat forebrain.
    J J Rutter and S B Auerbach
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1319-1324;
  • You have access
    Involvement of delta 2 opioid receptors in acute dependence on morphine in mice.
    Y Miyamoto, P S Portoghese and A E Takemori
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1325-1327;
  • You have access
    Structure-activity relationship for D-ring derivatives of grayanotoxin in the squid giant axon.
    M Yakehiro, S Yamamoto, N Baba, S Nakajima, J Iwasa and I Seyama
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1328-1332;
  • You have access
    Effect of genetic obesity and phenobarbital treatment on the hepatic conjugation pathways.
    I P Chaudhary, S Tuntaterdtum, P J McNamara, L W Robertson and R A Blouin
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1333-1338;
  • You have access
    Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    I Pham, W Gonzalez, A I el Amrani, M C Fournié-Zaluski, M Philippe, I Laboulandine, B P Roques and J B Michel
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1339-1347;
  • You have access
    The gastrin/cholecystokinin-B receptor antagonist L-365,260 reduces basal acid secretion and prevents gastrointestinal damage induced by aspirin, ethanol and cysteamine in the rat.
    C E Pendley, L R Fitzpatrick, R W Ewing, B F Molino and G E Martin
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1348-1354;
  • You have access
    Extracellular acidosis ameliorates metabolic-inhibitor-induced and potentiates oxidant-induced cell death in renal proximal tubules.
    D P Rodeheaver and R G Schnellmann
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1355-1360;
  • You have access
    Pentobarbital administered intracerebroventricularly antagonizes morphine-induced antinociception in mice.
    F S Wang and J M Fujimoto
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1361-1368;
  • You have access
    Pulmonary thromboembolism-induced alterations in nitric oxide release from rat circulating neutrophils.
    M Dikshit, R Kumari and R C Srimal
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1369-1373;
  • You have access
    The influence of estrus cycle on neurosteroid potency at the gamma-aminobutyric acidA receptor complex.
    D A Finn and K W Gee
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1374-1379;
  • You have access
    Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid.
    G Nowak, R Trullas, R T Layer, P Skolnick and I A Paul
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1380-1386;
  • You have access
    Relative potency and efficacy of some dopamine agonists with varying selectivities for D1 and D2 receptors in MPTP-induced hemiparkinsonian monkeys.
    E F Domino and J Sheng
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1387-1391;
  • You have access
    Neurochemical actions of inhalational anesthetics at the GABAA receptor complex.
    B Harris, G Wong and P Skolnick
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1392-1398;
  • You have access
    8-(Diethylamino)-octyl-3,4,5-trimethoxybenzoate inhibits cromakalim-induced 86Rb efflux from the rat aorta.
    N J Lodge and N N Halaka
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1399-1405;
  • You have access
    Stereoselectivity in glutathione conjugation and amidase-catalyzed hydrolysis of the 2-bromoisovalerylurea enantiomers in the single-pass perfused rat liver.
    M Polhuijs, I Gasinska, W F Cherry, G J Mulder and K S Pang
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1406-1412;
  • You have access
    Endothelin differentially affects rat gastric longitudinal and circular smooth muscle.
    J Fulginiti, M M Cohen and R S Moreland
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1413-1420;
  • You have access
    Differential actions of cisplatin on renal proximal tubule and inner medullary collecting duct cells.
    H R Brady, M L Zeidel, B C Kone, G Giebisch and S R Gullans
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1421-1428;
  • You have access
    Kinetics of sequential metabolism. I. Formation and metabolism of oxazepam from nordiazepam and temazepam in the perfused murine liver.
    M V St-Pierre and K S Pang
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1429-1436;
  • You have access
    Kinetics of sequential metabolism. II. Formation and metabolism of nordiazepam and oxazepam from diazepam in the perfused murine liver.
    M V St-Pierre and K S Pang
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1437-1445;
  • You have access
    Antinociceptive profile of biphalin, a dimeric enkephalin analog.
    P J Horan, A Mattia, E J Bilsky, S Weber, T P Davis, H I Yamamura, E Malatynska, S M Appleyard, J Slaninova and A Misicka
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1446-1454;
  • You have access
    Characterization of 4-aminopyridine block of the transient outward K+ current in adult rat ventricular myocytes.
    N A Castle and M T Slawsky
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1450-1459;
  • You have access
    Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes.
    M Alkondon and E X Albuquerque
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1455-1473;
  • You have access
    Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons.
    E F Pereira, S Reinhardt-Maelicke, A Schrattenholz, A Maelicke and E X Albuquerque
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1474-1491;
  • You have access
    Administration of 3,3'-iminodipropionitrile to the rat results in region-dependent damage to the central nervous system at levels above the brain stem.
    J Llorens, K M Crofton and J P O'Callaghan
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1492-1498;
  • You have access
    P2-purinergic receptors in human breast tumor cells: coupling of intracellular calcium signaling to anion secretion.
    M Flezar and S Heisler
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1499-1510;
  • You have access
    Effects of nicotine on brain stem mechanisms of cardiovascular control.
    C J Tseng, M Appalsamy, D Robertson and R Mosqueda-Garcia
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1511-1518;
  • You have access
    Quantitative analysis of concentration-response curves for precipitated abstinence responses in the opiate-dependent guinea pig ileum.
    S L Cruz, L A Salazar, A Fernández-Guasti and J E Villarreal
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1519-1526;
  • You have access
    Ionic mechanism of minoxidil sulfate-induced shortening of action potential durations in guinea pig ventricular myocytes.
    S Hayashi, M Horie and Y Okada
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1527-1533;
  • You have access
    Intrinsic properties of the nonpeptide angiotensin II antagonist losartan in glomeruli and mesangial cells at high concentrations.
    D Chansel, L Badre, S Czekalski, S Vandermeersch, J Cambar and R Ardaillou
    Journal of Pharmacology and Experimental Therapeutics June 1993, 265 (3) 1534-1543;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 265, Issue 3
1 Jun 1993
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Article
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Rho GTPase–Pathway Inhibitor Reduces Markers of Fibrosis
  • Nose-to-Brain Delivery
  • Stem Cells Therapies in AD
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics